BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3609146)

  • 1. Verapamil inhibition of 5-hydroxytryptamine (5HT) uptake in rat platelets.
    Pietraszek MH; Buczko W
    Eur J Pharmacol; 1987 Jun; 137(2-3):273-5. PubMed ID: 3609146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of verapamil on serotonergic mechanisms in the rat blood platelets.
    Pietraszek M; Chabielska E; Malinowska B; Buczko W
    Pol J Pharmacol Pharm; 1988; 40(1):81-6. PubMed ID: 3237561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil, an antagonist at 5-hydroxytryptamine receptors of human blood platelets.
    Affolter H; Burkard WP; Pletscher A
    Eur J Pharmacol; 1985 Jan; 108(2):157-62. PubMed ID: 3156755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of 14C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition. A comparative kinetic analysis.
    Wielosz M; Salmona M; de Gaetano G; Garattini S
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):59-65. PubMed ID: 1012348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of ketanserin, a novel serotonergic receptor antagonist, on 5HT-induced shape change and 5HT uptake in rat and human platelets.
    Lampugnani MG; de Gaetano G
    Biochem Pharmacol; 1982 Sep; 31(18):3000-2. PubMed ID: 7138588
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of steroids on the inhibition of platelet 5HT uptake by desipramine and other antidepressants.
    Lee PH; Chan MY
    Eur J Pharmacol; 1984 Nov; 106(2):255-62. PubMed ID: 6529976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference by fenfluramine with the storage of 14C-5-hydroxytryptamine in rat platelets.
    Wielosz M; Roncaglioni MC; de Gaetano G; Garattini S
    Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):232-9. PubMed ID: 849072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin uptake and imipramine binding in rat platelets after chronic dexamethasone and amitriptyline treatment.
    Chan MY; Lee PH
    Pharmacol Res Commun; 1985 Jul; 17(7):619-32. PubMed ID: 2996030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereospecific inhibition of 5-HT-induced increase of intracellular free calcium by (+)- and (-)-desmethoxyverapamil in human platelets.
    Bruns C; Marmé D; Osswald H
    Br J Pharmacol; 1986 Mar; 87(3):481-2. PubMed ID: 3801761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluation of the uptake of desoxyfructo-serotonin by human platelets, and of its effect on the uptake of serotonin.
    Costa JL; Kirk KL
    Res Commun Chem Pathol Pharmacol; 1979 Jul; 25(1):79-88. PubMed ID: 451361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nicotine on human blood platelet serotonin uptake and efflux.
    Rausch JL; Fefferman M; Ladisich-Rogers DG; Menard M
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):907-16. PubMed ID: 2813808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human platelet 5HT receptors: characterisation and functional association.
    Peters JR; Grahame-Smith DG
    Eur J Pharmacol; 1980 Dec; 68(3):243-56. PubMed ID: 7202490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal serotonin uptake by blood platelets and brain synaptosomes but selective impairment of platelet serotonin storage in mice with Chediack-Higashi syndrome.
    Lampugnani MG; Buczko W; Ceci A; Mennini A; de Gaetano G
    Life Sci; 1986 Jun; 38(24):2193-8. PubMed ID: 3713444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin effect on serotonin uptake and release in rat platelets: diurnal variation in responsiveness.
    Martín FJ; Atienza G; Aldegunde M; Míguez JM
    Life Sci; 1993; 53(13):1079-87. PubMed ID: 8366770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of rat platelet 5-hydroxytryptamine uptake by chlordimeform.
    Johnson TL; Knowles CO
    Toxicol Lett; 1981 Sep; 9(1):1-4. PubMed ID: 7302966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of urapidil on 5-hydroxytryptamine induced platelet aggregation and on 14C-5-hydroxytryptamine uptake in platelets.
    Storck J; Ochs JG; Kirsten R
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):303-8. PubMed ID: 2387654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood platelets as models for central 5-hydroxytryptaminergic neurons.
    Pletscher A; Laubscher A; Graf M; Saner A
    Ann Biol Clin (Paris); 1979; 37(1):35-9. PubMed ID: 443611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urapidil inhibits 5-hydroxytryptamine induced platelet aggregation and 14C-5-hydroxytryptamine uptake in platelets.
    Storck J; Kirsten R
    Curr Med Res Opin; 1990; 12(2):86-92. PubMed ID: 2390867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin uptake and its kinetics in platelets of women with Alzheimer's disease.
    Kumar AM; Kumar M; Sevush S; Ruiz J; Eisdorfer C
    Psychiatry Res; 1995 Nov; 59(1-2):145-50. PubMed ID: 8771229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of ten-second uptake periods for kinetic studies of serotonin uptake by intact platelets.
    Costa JL; Kirk KL; Stark H
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):547-58. PubMed ID: 7330456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.